SOTIO Biotech: SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline
PPF Group provides funding to advance SOTIO through key clinical milestonesProceeds shall be used to conduct two phase 2 studies with SOT101, including a checkpoint inhibitor combination trial Three programs